Literature DB >> 4175137

Nephropathy induced by D-penicillamine.

I A Jaffe, G Treser, Y Suzuki, T Ehrenreich.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4175137     DOI: 10.7326/0003-4819-69-3-549

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  16 in total

1.  Drug-induced renal diseases.

Authors:  A P Mukherjee
Journal:  Int Urol Nephrol       Date:  1974       Impact factor: 2.370

2.  Drug-induced nephropathies.

Authors:  H C Burry
Journal:  Proc R Soc Med       Date:  1973-09

3.  The effect of diosmin against lead exposure in rats.

Authors:  Mehmet Bozdağ; Gökhan Eraslan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-12-03       Impact factor: 3.000

4.  Pemphigus erythematosus-like rash in a patient on penicillamine.

Authors:  O Scherak; G Kolarz; K Molubar
Journal:  Br Med J       Date:  1977-03-26

Review 5.  Immunologically mediated glomerulonephritis induced by heavy metals.

Authors:  P Druet; A Bernard; F Hirsch; J J Weening; P Gengoux; P Mahieu; S Birkeland
Journal:  Arch Toxicol       Date:  1982-09       Impact factor: 5.153

Review 6.  Induction of auto-immune syndromes by penicillamine therapy in rheumatoid arthritis and other diseases.

Authors:  I A Jaffe
Journal:  Springer Semin Immunopathol       Date:  1981

7.  [Current problems of glomerulonephritis (author's transl)].

Authors:  W Thoenes
Journal:  Klin Wochenschr       Date:  1979-08-15

8.  Nephrotic syndrome induced by D-penicillamine therapy.

Authors:  P Jezersek; D Ferluga
Journal:  Int Urol Nephrol       Date:  1979       Impact factor: 2.370

9.  Polysaccharide accumulation in the central nervous system of D-penicillamine-treated rats.

Authors:  A P Jayaraj
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

10.  D-penicillamine and immune complex deposition.

Authors:  J D Kirby; P A Dieppe; E C Huskisson; B Smith
Journal:  Ann Rheum Dis       Date:  1979-08       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.